{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:16:05Z","timestamp":1778033765329,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"DOI":"10.7759\/cureus.108324","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:03:23Z","timestamp":1778033003000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Pitfalls in Adult-Onset Spinal Muscular Atrophy Type 4: When Incidental Lumbar Stenosis Confounds the Clinical Picture"],"prefix":"10.7759","author":[{"given":"Shamas","family":"Rafique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqra","family":"Rafiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre S","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, et al.. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995, 80:155-65. 10.1016\/0092-8674(95)90460-3","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e318220d523","article-title":"Technical standards and guidelines for spinal muscular atrophy testing","volume":"13","author":"Prior TW","year":"2011","unstructured":"Prior TW, Nagan N, Sugarman EA, Batish SD, Braastad C. Technical standards and guidelines for spinal muscular atrophy testing. Genet Med. 2011, 13:686-94. 10.1097\/GIM.0b013e318220d523","journal-title":"Genet Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter M","year":"2002","unstructured":"Feldk\u00f6tter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002, 70:358-68. 10.1086\/338627","journal-title":"Am J Hum Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14587","article-title":"Clinical and radiological profile of patients with spinal muscular atrophy type 4","volume":"28","author":"Souza PV","year":"2021","unstructured":"Souza PV, Pinto WB, Ricarte A, et al.. Clinical and radiological profile of patients with spinal muscular atrophy type 4. Eur J Neurol. 2021, 28:609-19. 10.1111\/ene.14587","journal-title":"Eur J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13534","article-title":"Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4","volume":"25","author":"Wadman RI","year":"2018","unstructured":"Wadman RI, Wijngaarde CA, Stam M, et al.. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4. Eur J Neurol. 2018, 25:512-8. 10.1111\/ene.13534","journal-title":"Eur J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4173","article-title":"Systematic literature review of imaging features of spinal degeneration in asymptomatic populations","volume":"36","author":"Brinjikji W","year":"2015","unstructured":"Brinjikji W, Luetmer PH, Comstock B, et al.. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015, 36:811-6. 10.3174\/ajnr.A4173","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.105356","article-title":"Anterior horn cell disease in adulthood: unmasking spinal muscular atrophy type 4","volume":"18","author":"Rafique S","year":"2026","unstructured":"Rafique S, Odeh A. Anterior horn cell disease in adulthood: unmasking spinal muscular atrophy type 4. Cureus. 2026, 18:e105356. 10.7759\/cureus.105356","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16117","article-title":"Disease spectrum of myopathies with elevated aldolase and normal creatine kinase","volume":"31","author":"Soontrapa P","year":"2024","unstructured":"Soontrapa P, Shahar S, Eauchai L, Ernste FC, Liewluck T. Disease spectrum of myopathies with elevated aldolase and normal creatine kinase. Eur J Neurol. 2024, 31:e16117. 10.1111\/ene.16117","journal-title":"Eur J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.161448","article-title":"High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology","volume":"80","author":"Nozaki K","year":"2009","unstructured":"Nozaki K, Pestronk A. High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology. J Neurol Neurosurg Psychiatry. 2009, 80:904-8. 10.1136\/jnnp.2008.161448","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2011.11.016","article-title":"Value of muscle enzyme measurement in evaluating different neuromuscular diseases","volume":"413","author":"Zhang Y","year":"2012","unstructured":"Zhang Y, Huang JJ, Wang ZQ, Wang N, Wu ZY. Value of muscle enzyme measurement in evaluating different neuromuscular diseases. Clin Chim Acta. 2012, 413:520-4. 10.1016\/j.cca.2011.11.016","journal-title":"Clin Chim Acta"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27008","article-title":"Evaluation of persons with suspected lumbosacral and cervical radiculopathy: electrodiagnostic assessment and implications for treatment and outcomes (part II)","volume":"62","author":"Dillingham TR","year":"2020","unstructured":"Dillingham TR, Annaswamy TM, Plastaras CT. Evaluation of persons with suspected lumbosacral and cervical radiculopathy: electrodiagnostic assessment and implications for treatment and outcomes (part II). Muscle Nerve. 2020, 62:474-84. 10.1002\/mus.27008","journal-title":"Muscle Nerve"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26788","article-title":"Clinical phenotype of pediatric and adult patients with spinal muscular atrophy with four SMN2 copies: are they really all stable?","volume":"94","author":"Ricci M","year":"2023","unstructured":"Ricci M, Cicala G, Capasso A, et al.. Clinical phenotype of pediatric and adult patients with spinal muscular atrophy with four SMN2 copies: are they really all stable?. Ann Neurol. 2023, 94:1126-35. 10.1002\/ana.26788","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","volume":"28","author":"Calucho M","year":"2018","unstructured":"Calucho M, Bernal S, Al\u00edas L, et al.. Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul Disord. 2018, 28:208-15. 10.1016\/j.nmd.2018.01.003","journal-title":"Neuromuscul Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2174\/1381612828666220329115433","article-title":"Treatment of adult spinal muscular atrophy: overview and recent developments","volume":"28","author":"Brakemeier S","year":"2022","unstructured":"Brakemeier S, Stolte B, Kleinschnitz C, Hagenacker T. Treatment of adult spinal muscular atrophy: overview and recent developments. Curr Pharm Des. 2022, 28:892-8. 10.2174\/1381612828666220329115433","journal-title":"Curr Pharm Des"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri E","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, et al.. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018, 378:625-35. 10.1056\/NEJMoa1710504","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/478527-diagnostic-pitfalls-in-adult-onset-spinal-muscular-atrophy-type-4-when-incidental-lumbar-stenosis-confounds-the-clinical-picture","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:03:28Z","timestamp":1778033008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/478527-diagnostic-pitfalls-in-adult-onset-spinal-muscular-atrophy-type-4-when-incidental-lumbar-stenosis-confounds-the-clinical-picture"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.108324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}